annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb)Â and successfully completed first production.(PRNewsfoto/Telix Pharmaceuticals Limited)
The new generator technology, developed internally by Telix's IsoTherapeutics team, produces 212Pb via a sealed Thorium-228 (228Th) source...
>>> Read more: Telix Adds Lead-212 Isotope Production Capability
The new generator technology, developed internally by Telix's IsoTherapeutics team, produces 212Pb via a sealed Thorium-228 (228Th) source...
>>> Read more: Telix Adds Lead-212 Isotope Production Capability